© 1996 American Heart Association, Inc.
Articles |
Autocrine Induction of DNA Synthesis by Mechanical Injury of Cultured Smooth Muscle Cells
Potential Role of FGF and PDGF
From the Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, Calif, and the Department of Cell and Molecular Biology (A.H.-N.), Karolinska Institute, and the Departments of Surgery (U.H.) and Medicine (J.N.), Karolinska Hospital, Stockholm, Sweden.
Correspondence to Jan Nilsson, King Gustaf Vth Research Institute, Karolinska Hospital, 171 76 Stockholm, Sweden.
Abstract To determine whether replication of arterial smooth muscle cells (SMCs) in response to mechanical injury would occur in the absence of serum and other cells, we created an in vitro model in which confluent, growth-arrested cultures of rat SMCs were injured by gentle pressure of a soft plastic tube and then kept in serum-free medium for up to 4 days. Replication of SMCs in and around the injury, as measured by tritiated thymidine incorporation, was noted within 24 hours and peaked at 48 hours after injury, whereas noninjured cells remained quiescent. An increased expression of platelet-derived growth factor (PDGF) A mRNA, noted 6 hours after injury, was followed by an increased PDGF AA immunoreactivity in SMCs in and around the zone of injury at 24 and 48 hours after injury. A PDGF A chain antisense oligonucleotide inhibited 87.0±4.0% (P<.005) of SMC replication in the injury zone, whereas the corresponding sense oligonucleotide reduced SMC replication by only 37.2%. An antibody to fibroblast growth factor (FGF) almost completely inhibited SMC replication in the injured zone, whereas an antibody to PDGF AA was without effect. Incubation of SMCs with FGF increased PDGF A mRNA levels in SMCs, and 5 µmol/L PDGF A antisense oligonucleotides reduced FGF-induced SMC replication by 62%. Taken together, these results demonstrate that injured rat SMCs in culture release FGF that activates DNA synthesis of neighboring SMCs both by a direct mechanism and by stimulating the production of PDGF AA.
Key Words: injury • growth factors • smooth muscle cells • antisense
This article has been cited by other articles:
 |
|
 |
|
  A. Strom, A. I. Olin, A. Aspberg, and A. Hultgardh-Nilsson Fibulin-2 is present in murine vascular lesions and is important for smooth muscle cell migration Cardiovasc Res, February 15, 2006; 69(3): 755 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Berk Vascular Smooth Muscle Growth: Autocrine Growth Mechanisms Physiol Rev, July 1, 2001; 81(3): 999 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Oguchi, P. Dimayuga, J. Zhu, K.-Y. Chyu, J. Yano, P. K. Shah, J. Nilsson, and B. Cercek Monoclonal Antibody Against Vascular Cell Adhesion Molecule-1 Inhibits Neointimal Formation After Periadventitial Carotid Artery Injury in Genetically Hypercholesterolemic Mice Arterioscler Thromb Vasc Biol, July 1, 2000; 20(7): 1729 - 1736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-Y. Chyu, P. Dimayuga, J. Zhu, J. Nilsson, S. Kaul, P. K. Shah, and B. Cercek Decreased Neointimal Thickening After Arterial Wall Injury in Inducible Nitric Oxide Synthase Knockout Mice Circ. Res., December 3, 1999; 85(12): 1192 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Hartnett, C. M. Garcia, and P. A. D’Amore Release of bFGF, an Endothelial Cell Survival Factor, by Osmotic Shock Invest. Ophthalmol. Vis. Sci., November 1, 1999; 40(12): 2945 - 2951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Heckenkamp, D. Leszczynski, J. Schiereck, J. Kung, and G. M. LaMuraglia Different Effects of Photodynamic Therapy and {gamma}-Irradiation on Vascular Smooth Muscle Cells and Matrix : Implications for Inhibiting Restenosis Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2154 - 2161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Khachigian, F. S. Santiago, L. A. Rafty, O. L.-W. Chan, G. J. Delbridge, A. Bobik, T. Collins, and A. C. Johnson GC Factor 2 Represses Platelet-Derived Growth Factor A-Chain Gene Transcription and Is Itself Induced by Arterial Injury Circ. Res., June 11, 1999; 84(11): 1258 - 1267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Yang, W. H. Briggs, P. Libby, and R. T. Lee Small Mechanical Strains Selectively Suppress Matrix Metalloproteinase-1 Expression by Human Vascular Smooth Muscle Cells J. Biol. Chem., March 13, 1998; 273(11): 6550 - 6555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Waltenberger Modulation of Growth Factor Action : Implications for the Treatment of Cardiovascular Diseases Circulation, December 2, 1997; 96(11): 4083 - 4094. [Abstract] [Full Text]
|
|
|
|
|
|
R. D. Kenagy, C. E. Hart, W. G. Stetler-Stevenson, and A. W. Clowes Primate Smooth Muscle Cell Migration From Aortic Explants Is Mediated by Endogenous Platelet-Derived Growth Factor and Basic Fibroblast Growth Factor Acting Through Matrix Metalloproteinases 2 and 9 Circulation, November 18, 1997; 96(10): 3555 - 3560. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. C. Major and J. A. Keiser Inhibition of Cell Growth: Effects of the Tyrosine Kinase Inhibitor CGP 53716 J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 402 - 410. [Abstract] [Full Text]
|
|
|
|
|
|
R. G Statius van Eps, F. Adili, and G. M LaMuraglia Photodynamic therapy inactivates cell-associated basic fibroblast growth factor: a silent way of vascular smooth muscle cell eradication Cardiovasc Res, August 1, 1997; 35(2): 334 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Cheng, W. H. Briggs, D. S. Gerson, P. Libby, A. J. Grodzinsky, M. L. Gray, and R. T. Lee Mechanical Strain Tightly Controls Fibroblast Growth Factor-2 Release From Cultured Human Vascular Smooth Muscle Cells Circ. Res., January 1, 1997; 80(1): 28 - 36. [Abstract] [Full Text]
|
|